AMS: Pelvic Mesh Plaintiffs Enticed
This article was originally published in The Gray Sheet
Executive Summary
Some plaintiffs in ongoing multi-district litigation against pelvic mesh manufacturer American Medical Systems were recruited to the case by cold-callers and did not need to have the mesh removed, the company argued in a recent court filing.
You may also be interested in...
Endo Unit Shutdown Could Strand Incontinence Treatment Praised By FDA Panel
Endo International plans to shutter its Astora Women's Health business unit – formerly part of American Medical Systems – this month due to ongoing legal concerns tied to the company’s vaginal mesh products. What’s unclear is what this means for the company’s investigational fecal incontinence treatment, which received unanimous support from an FDA advisory panel just days before the shutdown was announced.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.